Press release
Companion Animals Drug Market Value is Expected to Increase to US$ 44,727.3 Mn by 2025
Future Market Insights (FMI) delivers key insights on the global companion animals drug market in its upcoming outlook titled, “Companion Animals Drug Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025”. In terms of revenue, the global companion animal drug market is projected to register a healthy CAGR of 4.9% over the forecast period owing to various factors, which FMI analysis highlights and offers detailed insights and forecasts.The market is segmented based on product type, distribution channels and regions. The overall market has been segmented broadly into eight product types such as antibiotics, anti-inflammatory drugs, parasiticides (further sub-divided into ecto-parasiticides and endo-parasiticides), heartworm drugs, nutritional, behavioural and skincare drugs and vaccines. Parasiticides more frequently applied as a cure for flea and tick infestations, are estimated to account for maximum revenue share by product type in the global companion animal drug market by 2015 end. The parasiticide drug segment is expected to expand at a CAGR of 6.6% in terms of value during the forecast period. Other popular drugs used in companion animals include heartworm medicines and vaccines. The vaccines segment is expected to reach market value of US$ 1,760.4 Mn by 2025, expanding at a CAGR of ~3% over the forecast period.
View and Download TOC of Companion Animal Drug Market Research Report@ https://www.futuremarketinsights.com/reports/companion-animal-drug-market/toc
To provide deeper insight into drug dispensing and distribution channels, the report has also been segmented by distribution channels such as veterinary hospitals, veterinary clinics and pharmacies and drug stores. It has been observed and validated that pet owners globally prefer consulting veterinary doctors at hospitals and clinics and administering prescription drugs to their small companion pets. However, a new trend of referring to the Internet to find out disease pathogenesis and buying over-the-counter (OTC) drugs from retail pharmacies and drug stores has been fast picking up.
The primary trend in the companion animal drug market is an increase in pet adoption and humanization of pets globally. Other driving forces include increasing urbanization and growing affluence in emerging economies, increasing R&D for faster launch of first-in-line drugs, extension of patent approvals on formularies and growing demand for compounded medicines, as they are easily affordable and accessible. Factors restraining market growth include rising costs for R&D and lack of scope for innovation due to matured product portfolios.
Request and Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1077
This report assesses trends driving growth of each segment on global as well as regional levels, and offers potential strategic recommendations that could prove useful to drug makers planning to penetrate or enter the market. North America is estimated to dominate the companion animals drug market with maximum market share by end of 2015. North America and Western Europe are collectively expected to account for close to 50% of the total companion animals drug market share in terms of value by end of 2015. Among emerging markets, Latin America is estimated to witness highest CAGR of 6.0% over the forecast period, followed by Asia Pacific excluding Japan, due to increasing pet adoption and rise in geriatric population.
Some key players identified in the global companion animal drug market report include Zoetis Inc., Elanco (Eli Lilly), Merck Animal Health, Bayer Animal Healthcare, Merial (Sanofi), Boehringer Ingelheim GmbH, Virbac Animal Health and Ceva Santé Animale. We have discussed individual strategies followed by these companies in terms of enhancing drug portfolios, market consolidation and drug innovation pipelines. The report has been concluded with strategic recommendations for players already present in the market and also new players planning to enter the market, which could help them in the long run.
Buy Full Companion Animals Drug Market Report@ https://www.futuremarketinsights.com/checkout/1077
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Animals Drug Market Value is Expected to Increase to US$ 44,727.3 Mn by 2025 here
News-ID: 741948 • Views: …
More Releases from Future Market Insights
Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
The Tumor Profiling Market is entering a transformative decade, driven by precision oncology, liquid biopsy advancements, advanced sequencing technologies, and growing demand for personalized cancer treatment. As leading companies like Thermo Fisher Scientific, Illumina, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, and Agilent Technologies strengthen their product portfolios, the tumor profiling market is expected to witness sustained adoption across diagnostic laboratories, clinics, and hospitals.
"Explore trends before investing - request a sample…
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
The global Prescription Lens Market Share Analysis is entering a pivotal growth phase as aging populations, digital lifestyles, and advanced vision-care technologies reshape consumer needs. The market is projected to grow at a 3.7% CAGR and reach USD 62,666.2 million by 2035. As demand continues accelerating, leading brands are refining their strategies to serve evolving optical expectations.
"Explore trends before investing - request a sample report today!"
https://www.futuremarketinsights.com/reports/sample/rep-gb-20711
Market Momentum: What Is Powering…
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Mark …
The Peptide Microarray Market is entering a transformative phase driven by technology advancements, rising investment in proteomics, and expanding applications across diagnostics and drug discovery. According to projections, the peptide microarray market is set to reach USD 903.8 million by 2025, progressing steadily at a CAGR of 3.8% through 2035. Precision tools, proteomics infrastructure growth, and innovation in peptide profiling platforms continue to reshape the future of global healthcare innovation.
Explore…
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 203 …
The Japan Cold Laser Therapy Market is set for steady expansion as healthcare providers, manufacturers, and end users shift toward advanced non-invasive treatment technologies. The (Japan Cold Laser Therapy Market) is projected to rise from USD 7.2 million in 2025 to USD 12.0 million by 2035, reflecting a CAGR of 5.2%. Cold laser therapy is gaining recognition due to its ability to reduce inflammation, promote healing, and alleviate pain-without requiring…
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled…
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are the…
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,…
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report…
